MEDSTRxADE HEALTH, INC

Nasdaq trxadehealth.com


$ 20.38 $ -0.81 (-3.86 %)    

Tuesday, 16-Jul-2024 15:58:26 EDT
QQQ $ 496.22 $ 0.19 (0.04 %)
DIA $ 409.69 $ 7.30 (1.81 %)
SPY $ 564.93 $ 3.33 (0.59 %)
TLT $ 94.14 $ 1.31 (1.41 %)
GLD $ 228.28 $ 4.46 (1.99 %)
$ 20.18
$ 20.55
$ 0.00 x 0
$ 0.00 x 0
$ 19.51 - $ 20.82
$ 2.46 - $ 29.75
149,754
na
25.57M
$ 0.76
$ 6.27
TBD
na
na ($ 0.40)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 06-26-2024 03-31-2024 10-Q
2 04-22-2024 12-31-2023 10-K
3 01-16-2024 09-30-2023 10-Q
4 08-18-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-27-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 07-25-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 10-25-2021 09-30-2021 10-Q
12 07-26-2021 06-30-2021 10-Q
13 04-26-2021 03-31-2021 10-Q
14 03-29-2021 12-31-2020 10-K
15 10-26-2020 09-30-2020 10-Q
16 07-27-2020 06-30-2020 10-Q
17 05-04-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 10-28-2019 09-30-2019 10-Q
20 07-26-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-22-2019 12-31-2018 10-K
23 10-26-2018 09-30-2018 10-Q
24 07-27-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 03-02-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-30-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 04-20-2016 03-31-2016 10-Q
34 03-28-2016 12-31-2015 10-K
35 11-02-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 05-04-2015 03-31-2015 10-Q
38 03-23-2015 12-31-2014 10-K
39 10-30-2014 09-30-2014 10-Q
40 08-19-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Market-Moving News for June 27th
06/27/2024 12:37:40

CASI: 92% | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Prop...

 trxade-health-q1-eps-640-down-from-045-yoy

Trxade Health (NASDAQ:MEDS) reported quarterly losses of $(6.40) per share. This is a 1322.22 percent decrease over losses of $...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...